FindMyKOL

Todd Pulerwitz, MD

Basic profile

NewYork–Presbyterian Hospital

ORCID↗NPI↗
✓ Itemized record
RegionNew York, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Todd Pulerwitz is a Cardiology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 33 publications with 1,724 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
33publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

1,724citations

Citations across these publications.

21h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.6%
    Statin23.5%
    Rosuvastatin Calcium47%Atorvastatin Calcium47%Pravastatin Sodium4%Simvastatin2%
    Part D<11 patients
    Beta blocker18.2%
    Metoprolol Succinate49%Carvedilol24%Nebivolol Hcl18%Metoprolol Tartrate3%Atenolol2%Labetalol Hcl2%Carvedilol Er2%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    9.8%
    Factor Xa inhibitor8.3%
    Eliquis69%Xarelto31%
    Part D≥78 patients
    P2Y12 inhibitor1.1%
    Clopidogrel100%
    Part D≥20 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.2%
    SGLT2 inhibitor1%
    Farxiga72%Jardiance28%
    Part D<11 patients
    Proton pump inhibitor0.8%
    Pantoprazole Sodium100%
    Part D≥15 patients

    + 2 more classes in this area

Where care is delivered (Part B)12% facility · 88% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”